Twelve-week, randomized, placebo-controlled, multicenter study of the efficacy and tolerability of budesonide and formoterol in one metered-dose inhaler compared …

J Corren, PE Korenblat, CJ Miller, CD O'Brien… - Clinical …, 2007 - Elsevier
BACKGROUND:: The addition of the long-acting β2-adrenergic agonist formoterol to low-to
moderate-dose budesonide has shown clinical efficacy in patients with persistent asthma …
被引用次数：72 相关文章

Twelve-week, randomized, placebo-controlled, multicenter study of the efficacy and tolerability of budesonide and formoterol in one metered-dose inhaler compared …

J Corren, PE Korenblat, CJ Miller, CD O'Brien… - Clinical …, 2007 - europepmc.org
Background The addition of the long-acting beta (2)-adrenergic agonist formoterol to low-to
moderate-dose budesonide has shown clinical efficacy in patients with persistent asthma …

Twelve-week, randomized, placebo-controlled, multicenter study of the efficacy and tolerability of budesonide and formoterol in one metered-dose inhaler compared …

J Corren, PE Korenblat, CJ Miller, CD O'Brien… - 2007 - pubmed.ncbi.nlm.nih.gov
Background The addition of the long-acting beta (2)-adrenergic agonist formoterol to low-to
moderate-dose budesonide has shown clinical efficacy in patients with persistent asthma …

Twelve-week, randomized, placebo-controlled, multicenter study of the efficacy and tolerability of budesonide and formoterol in one metered-dose inhaler compared …

J Corren, PE Korenblat, CJ Miller, CD O'Brien… - Clinical …, 2007 - infona.pl
The addition of the long-acting β 2-adrenergic agonist formoterol to low-to moderate-dose
budesonide has shown clinical efficacy in patients with persistent asthma. Combination …

[引用][C] Twelve-week, randomized, placebo-controlled, multicenter study of the efficacy and tolerability of budesonide and formoterol in one metered-dose inhaler …

J CORREN, PE KORENBLAT, CJ MILLER… - Clinical …, 2007 - pascal-francis.inist.fr
Twelve-week, randomized, placebo-controlled, multicenter study of the efficacy and tolerability of
budesonide and formoterol in one metered-dose inhaler compared with budesonide alone and …

Twelve-week, randomized, placebo-controlled, multicenter study of the efficacy and tolerability of budesonide and formoterol in one metered-dose inhaler compared …

J Corren, PE Korenblat, CJ Miller… - Clinical …, 2007 - clinicaltherapeutics.com
Background: The addition of the long-acting β 2-adrenergic agonist formoterol to low-to
moderate-dose budesonide has shown clinical efficacy in patients with persistent asthma …

[引用][C] Twelve-week, randomized, placebo-controlled, multicenter study of the efficacy and tolerability of budesonide and formoterol in one metered-dose inhaler …

J Corren, PE Korenblat, CJ Miller, CD O'Brien… - Clinical …, 2007 - Elsevier Limited

[引用][C] Twelve-week, randomized, placebo-controlled, multicenter study of the efficacy and tolerability of budesonide and formoterol in one metered-dose inhaler …

J CORREN, PE KORENBLAT, CJ MILLER… - Clinical …, 2007 - Elsevier